Skip to content

Diabetes mellitus and its management with unani medicine

Clincal study of ziabetes-e-shakari(Diabetes mellitus type II) and its management with unani medicine

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/10/046705
Enrollment
40
Registered
2022-10-21
Start date
Unknown
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications Health Condition 2: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Unani drugs Gymnema sylvestre(3 grams) Trigonella foenum graecum(3 grams): 6 grams of powder to be given per oral twice daily with water before meal for 40 days Control Intervention1:

Sponsors

PG DEPARTMENT OF MOALEJAT GENERAL MEDICINE GOVT.NIZAMIA TIBBI COLLEGE AND GENERAL HOSPITAL
Lead Sponsor
GOVTNIZAMIA TIBBI COLLEGE AND GENERAL HOSPITAL
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1.HBA1C 6.5gm% TO 7.5gm% 2.DIABETIC NEUROPATHY 3.FBS 120 TO 160mg/dl 4.PLBS 180 TO 300 mg/dl

Exclusion criteria

Exclusion criteria: 1.TYPE 1 DIABETES 2.PREGNANT AND LACTATING WOMEN 3.DIABETES WITH CARDIOVASCULAR DISEASE 4.DIABETES WITH RENAL DISORDER 5.MALIGNANCY 6.DIABETIC KETOACIDOSIS 7.SUBJECTS ON INSULIN THERAPY

Design outcomes

Primary

MeasureTime frame
TO ACHIEVE THE BLOOD GLUCOSE LEVELS IN NORMAL RANGE. i.e FBS - 70 TO 110. PLBS- 120 TO 180Timepoint: EVERY 10 th DAY FOR 40 DAYS

Secondary

MeasureTime frame
DECREASE IN SYMPTOMS OF POLYDIPSIA, POLYPHAGIA, POYURIATimepoint: EVERY 10 th DAY FOR 40 DAYS

Countries

India

Contacts

Public ContactDRSHAIKH ATEEQUR RAHMAN

GOVT NIZAMIA TIBBI COLLEGE AND GENERAL HOSPITAL

dr.faroqui@gmail.com9849139356

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026